Comparison of the nucleotide sequences of diabetogenic and nondiabetogenic encephalomyocarditis virus

Stuart H Cohen, Robert K. Naviaux, Kurt M. Vanden Brink, George W. Jordan

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The nucleotide sequences of a diabetogenic variant of encephalomyocarditis (EMC) virus (D variant, ifp- phenotype) and a nondiabetogenic variant of EMC virus (B variant, ifp+ phenotype) have been compared. These variants differ at eight sites. The poly(C) tract of EMC-B is three bases shorter than that of EMC-D. Of the seven sites at which nucleotide substitutions were confirmed using RNA templates, four resulted in amino acid changes in three different proteins, the leader peptide, t B (VP2), and 1D (VPI ). The biological significance of these differences can now be investigated.

Original languageEnglish (US)
Pages (from-to)603-607
Number of pages5
JournalVirology
Volume166
Issue number2
DOIs
StatePublished - 1988

Fingerprint

Encephalomyocarditis virus
Poly C
Phenotype
Protein Sorting Signals
Nucleotides
RNA
Amino Acids
Proteins
peptide B

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Comparison of the nucleotide sequences of diabetogenic and nondiabetogenic encephalomyocarditis virus. / Cohen, Stuart H; Naviaux, Robert K.; Vanden Brink, Kurt M.; Jordan, George W.

In: Virology, Vol. 166, No. 2, 1988, p. 603-607.

Research output: Contribution to journalArticle

Cohen, Stuart H ; Naviaux, Robert K. ; Vanden Brink, Kurt M. ; Jordan, George W. / Comparison of the nucleotide sequences of diabetogenic and nondiabetogenic encephalomyocarditis virus. In: Virology. 1988 ; Vol. 166, No. 2. pp. 603-607.
@article{5b7abac243d848549304faeda035e222,
title = "Comparison of the nucleotide sequences of diabetogenic and nondiabetogenic encephalomyocarditis virus",
abstract = "The nucleotide sequences of a diabetogenic variant of encephalomyocarditis (EMC) virus (D variant, ifp- phenotype) and a nondiabetogenic variant of EMC virus (B variant, ifp+ phenotype) have been compared. These variants differ at eight sites. The poly(C) tract of EMC-B is three bases shorter than that of EMC-D. Of the seven sites at which nucleotide substitutions were confirmed using RNA templates, four resulted in amino acid changes in three different proteins, the leader peptide, t B (VP2), and 1D (VPI ). The biological significance of these differences can now be investigated.",
author = "Cohen, {Stuart H} and Naviaux, {Robert K.} and {Vanden Brink}, {Kurt M.} and Jordan, {George W.}",
year = "1988",
doi = "10.1016/0042-6822(88)90534-X",
language = "English (US)",
volume = "166",
pages = "603--607",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Comparison of the nucleotide sequences of diabetogenic and nondiabetogenic encephalomyocarditis virus

AU - Cohen, Stuart H

AU - Naviaux, Robert K.

AU - Vanden Brink, Kurt M.

AU - Jordan, George W.

PY - 1988

Y1 - 1988

N2 - The nucleotide sequences of a diabetogenic variant of encephalomyocarditis (EMC) virus (D variant, ifp- phenotype) and a nondiabetogenic variant of EMC virus (B variant, ifp+ phenotype) have been compared. These variants differ at eight sites. The poly(C) tract of EMC-B is three bases shorter than that of EMC-D. Of the seven sites at which nucleotide substitutions were confirmed using RNA templates, four resulted in amino acid changes in three different proteins, the leader peptide, t B (VP2), and 1D (VPI ). The biological significance of these differences can now be investigated.

AB - The nucleotide sequences of a diabetogenic variant of encephalomyocarditis (EMC) virus (D variant, ifp- phenotype) and a nondiabetogenic variant of EMC virus (B variant, ifp+ phenotype) have been compared. These variants differ at eight sites. The poly(C) tract of EMC-B is three bases shorter than that of EMC-D. Of the seven sites at which nucleotide substitutions were confirmed using RNA templates, four resulted in amino acid changes in three different proteins, the leader peptide, t B (VP2), and 1D (VPI ). The biological significance of these differences can now be investigated.

UR - http://www.scopus.com/inward/record.url?scp=0023710558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023710558&partnerID=8YFLogxK

U2 - 10.1016/0042-6822(88)90534-X

DO - 10.1016/0042-6822(88)90534-X

M3 - Article

C2 - 2845665

AN - SCOPUS:0023710558

VL - 166

SP - 603

EP - 607

JO - Virology

JF - Virology

SN - 0042-6822

IS - 2

ER -